PFM Health Sciences’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.8M Buy
519,016
+19,179
+4% +$413K 1.27% 28
2026
Q1
$5.73M Hold
499,837
0.52% 59
2025
Q4
$7.18M Sell
499,837
-320,805
-39% -$5.55M 0.72% 43
2025
Q3
$15.5M Buy
820,642
+85,609
+12% +$1.41M 1.19% 28
2025
Q2
$15.8M Sell
735,033
-125,788
-15% -$1.87M 1.34% 25
2025
Q1
$11.3M Hold
860,821
0.82% 30
2024
Q4
$11.6M Hold
860,821
0.72% 40
2024
Q3
$18.3M Hold
860,821
1.03% 31
2024
Q2
$13.6M Hold
860,821
0.67% 43
2024
Q1
$12.8M Buy
860,821
+524,655
+156% +$7.19M 0.6% 49
2023
Q4
$3.08M Hold
336,166
0.18% 57
2023
Q3
$1.87M Hold
336,166
0.09% 70
2023
Q2
$2.71M Buy
+336,166
New +$2.48M 0.11% 76

Other funds holding OSCR

PFM Health Sciences's OSCR Position: Q2 2026 in Review

PFM Health Sciences increased its Oscar Health (OSCR) stake by 3.8% in Q2 2026, buying an estimated $413K and bringing the position to 519,016 shares worth $14.8M. The position accounts for 1.27% of the portfolio, ranked #28.

PFM Health Sciences first reported a position in OSCR in Q2 2023 and has held it in 13 quarters since. The position peaked at $18.3M in Q3 2024. 402 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • PFM Health Sciences held 519,016 shares of Oscar Health worth $14.8M as of Q2 2026.
  • PFM Health Sciences bought 19,179 Oscar Health shares in Q2 2026, an estimated $413K.
  • Oscar Health made up 1.27% of PFM Health Sciences's portfolio in Q2 2026, its #28 holding.
  • PFM Health Sciences first reported a position in Oscar Health in Q2 2023 and has held it in 13 quarters since.
  • PFM Health Sciences's Oscar Health position peaked at $18.3M in Q3 2024.
  • 402 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.